-
1
-
-
0025359399
-
Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors
-
Andersson T, Wilander E, Eriksson B, Lindgren PG, Oberg K (1990) Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors. Cancer Res 50:3413-3415
-
(1990)
Cancer Res
, vol.50
, pp. 3413-3415
-
-
Andersson, T.1
Wilander, E.2
Eriksson, B.3
Lindgren, P.G.4
Oberg, K.5
-
2
-
-
0027215419
-
Somatostatin analogue phase I trials in neuroendocrine neoplasms
-
Anthony L, Johnson D, Hande K, Shaff M, Winn S, Krozely M, Oates J (1993) Somatostatin analogue phase I trials in neuroendocrine neoplasms. Acta Oncol 32:217-223
-
(1993)
Acta Oncol
, vol.32
, pp. 217-223
-
-
Anthony, L.1
Johnson, D.2
Hande, K.3
Shaff, M.4
Winn, S.5
Krozely, M.6
Oates, J.7
-
3
-
-
0035040838
-
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
-
Aparicio T, Ducreux M, Baudin E, Sabourin J-C, De Baere T, Mitry E, Schlumberger M, Rougier P (2001) Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours. Eur J Cancer 37:1014-1019
-
(2001)
Eur J Cancer
, vol.37
, pp. 1014-1019
-
-
Aparicio, T.1
Ducreux, M.2
Baudin, E.3
Sabourin, J.-C.4
De Baere, T.5
Mitry, E.6
Schlumberger, M.7
Rougier, P.8
-
4
-
-
0027235493
-
Gastroenteropancreatic endocrine tumours: Effect of Sandostatin on tumour growth
-
The German Sandostatin Study Group
-
Arnold R, Benning R, Neuhaus C, Rolwage M, Trautmann ME (1993). Gastroenteropancreatic endocrine tumours: effect of Sandostatin on tumour growth. The German Sandostatin Study Group. Digestion 54 (Suppl 1):72-75
-
(1993)
Digestion
, vol.54
, Issue.SUPPL. 1
, pp. 72-75
-
-
Arnold, R.1
Benning, R.2
Neuhaus, C.3
Rolwage, M.4
Trautmann, M.E.5
-
5
-
-
0029866470
-
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours
-
Amold R, Trautmann ME, Creutzfeldt W, Benning R, Benning M, Neuhaus C, Jurgensen R, Stein K, Schafer H, Bruns C, Dennler HJ (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38:430-438
-
(1996)
Gut
, vol.38
, pp. 430-438
-
-
Amold, R.1
Trautmann, M.E.2
Creutzfeldt, W.3
Benning, R.4
Benning, M.5
Neuhaus, C.6
Jurgensen, R.7
Stein, K.8
Schafer, H.9
Bruns, C.10
Dennler, H.J.11
-
6
-
-
0025913153
-
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide
-
Creutzfeldt W, Bartsch HH, Jacubaschke U, Stockmann F (1991) Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncol 30:529-535
-
(1991)
Acta Oncol
, vol.30
, pp. 529-535
-
-
Creutzfeldt, W.1
Bartsch, H.H.2
Jacubaschke, U.3
Stockmann, F.4
-
7
-
-
0034103423
-
Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells
-
Detjen KM, Welzel M, Farwig K, Brembeck FH, Kaiser A, Riecken EO, Wiedenmann B, Rosewicz S (2000) Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells. Gastroenterology 118:735-748
-
(2000)
Gastroenterology
, vol.118
, pp. 735-748
-
-
Detjen, K.M.1
Welzel, M.2
Farwig, K.3
Brembeck, F.H.4
Kaiser, A.5
Riecken, E.O.6
Wiedenmann, B.7
Rosewicz, S.8
-
8
-
-
13344295073
-
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group
-
Di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, Zilembo N, di Leo A (1996) Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 77:402-408
-
(1996)
Cancer
, vol.77
, pp. 402-408
-
-
Di Bartolomeo, M.1
Bajetta, E.2
Buzzoni, R.3
Mariani, L.4
Carnaghi, C.5
Somma, L.6
Zilembo, N.7
Di Leo, A.8
-
9
-
-
0029987910
-
Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors-an antiangiogenic effect?
-
Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom (1996) Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors-an antiangiogenic effect? Anticancer Drugs 7:175-181
-
(1996)
Anticancer Drugs
, vol.7
, pp. 175-181
-
-
Dirix, L.Y.1
Vermeulen, P.B.2
Fierens, H.3
De Schepper, B.4
Corthouts, B.5
Van Oosterom6
-
10
-
-
0025835971
-
Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha
-
Doberauer C, Mengelkoch B, Kloke O, Wandl U, Niederle N (1991) Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha. Acta Oncol 30:603-605
-
(1991)
Acta Oncol
, vol.30
, pp. 603-605
-
-
Doberauer, C.1
Mengelkoch, B.2
Kloke, O.3
Wandl, U.4
Niederle, N.5
-
11
-
-
0033756265
-
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
-
Ducreux M, Ruszniewski P, Chayvialle JA, Blumberg J, Cloarec D, Michel H, Raymond JM, Dupas JL, Gouerou H, Jian R, Genestin E, Hammel P, Rougier P (2000) The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol 95:3276-3281
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 3276-3281
-
-
Ducreux, M.1
Ruszniewski, P.2
Chayvialle, J.A.3
Blumberg, J.4
Cloarec, D.5
Michel, H.6
Raymond, J.M.7
Dupas, J.L.8
Gouerou, H.9
Jian, R.10
Genestin, E.11
Hammel, P.12
Rougier, P.13
-
12
-
-
0030667438
-
High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects
-
Eriksson B, Renstrup J, Imam H, Oberg K (1997) High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. Ann Oncol 8:1041-1044
-
(1997)
Ann Oncol
, vol.8
, pp. 1041-1044
-
-
Eriksson, B.1
Renstrup, J.2
Imam, H.3
Oberg, K.4
-
13
-
-
0043132282
-
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - The International Lanreotide and Interferon Alfa Study Group
-
Faiss S, Pape UF, Bohmig M, Dorffel Y, Mansmann U, Golder W, Riecken EO, Wiedenmann B;International Lanreotide and Interferon Alfa Study Group (2003) Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol 21:2689-2696
-
(2003)
J Clin Oncol
, vol.21
, pp. 2689-2696
-
-
Faiss, S.1
Pape, U.F.2
Bohmig, M.3
Dorffel, Y.4
Mansmann, U.5
Golder, W.6
Riecken, E.O.7
Wiedenmann, B.8
-
14
-
-
0344132653
-
Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors
-
Faiss S, Rath U, Mansmann U, Caird D, Clemens N, Riecken EO, Wiedenmann B (1999) Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors. Digestion 60:469-476
-
(1999)
Digestion
, vol.60
, pp. 469-476
-
-
Faiss, S.1
Rath, U.2
Mansmann, U.3
Caird, D.4
Clemens, N.5
Riecken, E.O.6
Wiedenmann, B.7
-
16
-
-
0033135279
-
Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors
-
Frank M, Klose KJ, Wied M, Ishaque N, Schade-Brittinger C, Arnold R. (1999) Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 94:1381-1387
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1381-1387
-
-
Frank, M.1
Klose, K.J.2
Wied, M.3
Ishaque, N.4
Schade-Brittinger, C.5
Arnold, R.6
-
17
-
-
0025916258
-
In situ hybridization for detection of hormone and peptide mRNA in carcinoid tumors
-
Funa K (1991) In situ hybridization for detection of hormone and peptide mRNA in carcinoid tumors Acta Oncol 30:457-461
-
(1991)
Acta Oncol
, vol.30
, pp. 457-461
-
-
Funa, K.1
-
18
-
-
0025064525
-
Interferon-induced enhancement of 2′,5′-oligoadenylate synthetase in mid-gut carcinoid tumours
-
Grander D, Oberg K, Lundqvist ML, Janson ET, Eriksson B, Einhorn S (1990) Interferon-induced enhancement of 2′,5′-oligoadenylate synthetase in mid-gut carcinoid tumours. Lancet 336:337-340
-
(1990)
Lancet
, vol.336
, pp. 337-340
-
-
Grander, D.1
Oberg, K.2
Lundqvist, M.L.3
Janson, E.T.4
Eriksson, B.5
Einhorn, S.6
-
19
-
-
0037323565
-
The pathophysiological consequences of somatostatin receptor internalization and resistance
-
Hofland LJ, Lamberts SW (2003) The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24:28-47
-
(2003)
Endocr Rev
, vol.24
, pp. 28-47
-
-
Hofland, L.J.1
Lamberts, S.W.2
-
20
-
-
0028983495
-
Interferon-alpha 2b, with or without prior hepatic artery embolization: Clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study
-
Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A (1995) Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol 30:789-796
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 789-796
-
-
Jacobsen, M.B.1
Hanssen, L.E.2
Kolmannskog, F.3
Schrumpf, E.4
Vatn, M.H.5
Bergan, A.6
-
21
-
-
0027241110
-
Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon
-
Janson ET, Oberg K (1993) Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncol 32:225-229
-
(1993)
Acta Oncol
, vol.32
, pp. 225-229
-
-
Janson, E.T.1
Oberg, K.2
-
22
-
-
0026670264
-
Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: A randomized trial
-
Janson ET, Ronnblom L, Ahlstrom H, Grander D, Alm G, Einhorn S, Oberg K (1992) Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial. Ann Oncol 3:635-638
-
(1992)
Ann Oncol
, vol.3
, pp. 635-638
-
-
Janson, E.T.1
Ronnblom, L.2
Ahlstrom, H.3
Grander, D.4
Alm, G.5
Einhorn, S.6
Oberg, K.7
-
23
-
-
0002959892
-
Zollinger-Ellison Syndrome
-
Doherty GM, Skögseid B (eds). Lippincott Williams & Wilkins, Philadelphia
-
Jensen RT (2001) Zollinger-Ellison Syndrome. In: Doherty GM, Skögseid B (eds) Surgical Endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 291-343
-
(2001)
Surgical Endocrinology
, pp. 291-343
-
-
Jensen, R.T.1
-
24
-
-
0022510433
-
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue
-
Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG (1986) Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 315:663-666
-
(1986)
N Engl J Med
, vol.315
, pp. 663-666
-
-
Kvols, L.K.1
Moertel, C.G.2
O'Connell, M.J.3
Schutt, A.J.4
Rubin, J.5
Hahn, R.G.6
-
25
-
-
0024335905
-
Therapeutic considerations for the malignant carcinoid syndrome
-
Kvols LK (1989) Therapeutic considerations for the malignant carcinoid syndrome. Acta Oncol 28:433-438
-
(1989)
Acta Oncol
, vol.28
, pp. 433-438
-
-
Kvols, L.K.1
-
26
-
-
0026041670
-
The role of somatostatin and its analogs in the diagnosis and treatment of tumors
-
Lamberts SWJ, Krenning EP, Reubi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 12:450-482
-
(1991)
Endocrine Rev
, vol.12
, pp. 450-482
-
-
Lamberts, S.W.J.1
Krenning, E.P.2
Reubi, J.C.3
-
27
-
-
84862374785
-
Neuroendokrine tumore des gastrointestinal-traktes
-
Lehnert H (Hrsg). Thieme, Stuttgart
-
Lehnert H, Becker W, Dralle H, Wiedenmann B, Plöckinger U (2003) Neuroendokrine Tumore des Gastrointestinal-Traktes. In: Lehnert H (Hrsg) Rationelle Diagnostik und Therapie in der Endokrinologie. Thieme, Stuttgart, S 91-213
-
(2003)
Rationelle Diagnostik und Therapie in der Endokrinologie
, pp. 91-213
-
-
Lehnert, H.1
Becker, W.2
Dralle, H.3
Wiedenmann, B.4
Plöckinger, U.5
-
28
-
-
0025046253
-
Antitumor effects of somatostatin mediated by the stimulation of tyrosin-phosphatase
-
Liebow C, Lee MT, Schally A (1990) Antitumor effects of somatostatin mediated by the stimulation of tyrosin-phosphatase. Metabolism 39 (Suppl 2):163-166
-
(1990)
Metabolism
, vol.39
, Issue.SUPPL. 2
, pp. 163-166
-
-
Liebow, C.1
Lee, M.T.2
Schally, A.3
-
29
-
-
0024508014
-
Use of long-acting somatostatin analogue SMS 201-99S in patients with pancreatic islet cell tumors
-
Maton PN, Garnder JD, Jensen RT (1989) Use of long-acting somatostatin analogue SMS 201-99S in patients with pancreatic islet cell tumors. Dig Dis Sci 34:285-291
-
(1989)
Dig Dis Sci
, vol.34
, pp. 285-291
-
-
Maton, P.N.1
Garnder, J.D.2
Jensen, R.T.3
-
30
-
-
0024341413
-
Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon
-
Moertel CG, Rubin J, Kvols LK (1989) Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7:865-868
-
(1989)
J Clin Oncol
, vol.7
, pp. 865-868
-
-
Moertel, C.G.1
Rubin, J.2
Kvols, L.K.3
-
31
-
-
0028269720
-
Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha
-
Nold R, Frank M, Kajdan U, Trost U, Klose KJ, Arnold R (1994) Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha Z Gastroenterol 32:193-197
-
(1994)
Z Gastroenterol
, vol.32
, pp. 193-197
-
-
Nold, R.1
Frank, M.2
Kajdan, U.3
Trost, U.4
Klose, K.J.5
Arnold, R.6
-
32
-
-
0024523620
-
Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: Development of neutralizing interferon antibodies and possible loss of antitumor activity
-
Öberg K, Alm G, Magnusson A, Lundqvist G, Theodorsson E, Wide L, Wilander E (1989) Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. J Natl Cancer Inst 81:531-535
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 531-535
-
-
Öberg, K.1
Alm, G.2
Magnusson, A.3
Lundqvist, G.4
Theodorsson, E.5
Wide, L.6
Wilander, E.7
-
33
-
-
0025743467
-
The role of interferons in the management of carcinoid tumors
-
Öberg K, Eriksson B (1991) The role of interferons in the management of carcinoid tumors. Acta Oncol 30:519-522
-
(1991)
Acta Oncol
, vol.30
, pp. 519-522
-
-
Öberg, K.1
Eriksson, B.2
-
34
-
-
0023038741
-
Treatment of malignant carcinoid tumors with human leukocyte interferon: Long-term results
-
Öberg K, Norheim I, Lind E, Alm G, Lundqvist G, Wide L, Jonsdottir B, Magnusson A, Wilander E (1986) Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep 70:1297-1304
-
(1986)
Cancer Treat Rep
, vol.70
, pp. 1297-1304
-
-
Öberg, K.1
Norheim, I.2
Lind, E.3
Alm, G.4
Lundqvist, G.5
Wide, L.6
Jonsdottir, B.7
Magnusson, A.8
Wilander, E.9
-
35
-
-
0026682699
-
G-protein activation of a hormone stimulated phosphatase in human tumor cells
-
Pan MG, Florio T, Stork PJS (1992) G-protein activation of a hormone stimulated phosphatase in human tumor cells. Science 256:1215-1217
-
(1992)
Science
, vol.256
, pp. 1215-1217
-
-
Pan, M.G.1
Florio, T.2
Stork, P.J.S.3
-
36
-
-
0025641087
-
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
-
Plöckinger U, Dienemann D, Quabbe HJ (1990) Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocrinol Metab 71:1658-1662
-
(1990)
J Clin Endocrinol Metab
, vol.71
, pp. 1658-1662
-
-
Plöckinger, U.1
Dienemann, D.2
Quabbe, H.J.3
-
37
-
-
2342651677
-
Systemic therapy for metastatic or residual extrapancreatic endocrine tumors
-
Doherty GM, Skögseid B (eds). Lippincott Williams & Wilkins, Philadelphia
-
Plöckinger U, Wiedenmann B (2001) Systemic therapy for metastatic or residual extrapancreatic endocrine tumors. In: Doherty GM, Skögseid B (eds) Surgical Endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 461-476
-
(2001)
Surgical Endocrinology
, pp. 461-476
-
-
Plöckinger, U.1
Wiedenmann, B.2
-
38
-
-
0036053655
-
Neuroendocrine tumors of the gastro-entero pancreatic GEP system: The role of early diagnosis, genetic testing and preventive surgery
-
Plöckinger U, Wiedenmann B (2002) Neuroendocrine tumors of the gastro-entero pancreatic GEP system: The role of early diagnosis, genetic testing and preventive surgery. Digestive Diseases 20
-
(2002)
Digestive Diseases
, pp. 20
-
-
Plöckinger, U.1
Wiedenmann, B.2
-
39
-
-
6044240296
-
Treatment of non-functioning gastroenteropancreatic tumors
-
Lamberts SWJ, Dogliotti L (Hrsg). BioScientifica Ltd, Bristol
-
Plöckinger U, Wiedenmann B (2002) Treatment of non-functioning gastroenteropancreatic tumors. In: Lamberts SWJ, Dogliotti L (Hrsg) The Expanding Role of Octreotide I: Advances in Oncology. BioScientifica Ltd, Bristol 113-141
-
(2002)
The Expanding Role of Octreotide I: Advances in Oncology
, pp. 113-141
-
-
Plöckinger, U.1
Wiedenmann, B.2
-
40
-
-
0033783951
-
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
-
Ricci S, Antonuzzo A, Galli L, Ferdeghini M, Bodei L, Orlandini C, Conte PF (2000) Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Ann Oncol 11:1127-1130
-
(2000)
Ann Oncol
, vol.11
, pp. 1127-1130
-
-
Ricci, S.1
Antonuzzo, A.2
Galli, L.3
Ferdeghini, M.4
Bodei, L.5
Orlandini, C.6
Conte, P.F.7
-
41
-
-
0024213731
-
Oncological applications of somatostatin analogues
-
Schally AV (1988) Oncological applications of somatostatin analogues. Cancer Res 48:6977-6985
-
(1988)
Cancer Res
, vol.48
, pp. 6977-6985
-
-
Schally, A.V.1
-
42
-
-
0023484084
-
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor
-
Smith DB, Scarffe JH, Wagstaff J, Johnston RJ (1987) Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor. Cancer Treat Rep 71:1265-1266
-
(1987)
Cancer Treat Rep
, vol.71
, pp. 1265-1266
-
-
Smith, D.B.1
Scarffe, J.H.2
Wagstaff, J.3
Johnston, R.J.4
-
43
-
-
0028878664
-
Somatostatin inhibits AP-1 function via multiple protein phosphatases
-
Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T (1995) Somatostatin inhibits AP-1 function via multiple protein phosphatases. J Physiol 296:G160-G166
-
(1995)
J Physiol
, vol.296
-
-
Todisco, A.1
Seva, C.2
Takeuchi, Y.3
Dickinson, C.J.4
Yamada, T.5
-
45
-
-
0032173263
-
Slow-release lanreotide treatment in endocrine gastrointestinal tumors
-
S. Tomassetti P, Migliori M, Gullo L (1998) Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Am J Gastroenterol 93:1468-1471
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 1468-1471
-
-
Tomassetti, S.P.1
Migliori, M.2
Gullo, L.3
-
46
-
-
0026024113
-
Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
-
Valimaki M, Jarvinen H, Salmela P, Sane T, Sjoblom SM, Pelkonen R (1991) Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer 67:547-549
-
(1991)
Cancer
, vol.67
, pp. 547-549
-
-
Valimaki, M.1
Jarvinen, H.2
Salmela, P.3
Sane, T.4
Sjoblom, S.M.5
Pelkonen, R.6
-
47
-
-
0032960694
-
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms
-
Wymenga AN, Eriksson B, Salmela PI, Jacobsen MB, Van Cutsem EJ, Fiasse RH, Valimaki MJ, Renstrup J, de Vries EG, Oberg KE (1999) Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol 17:1111-1115
-
(1999)
J Clin Oncol
, vol.17
, pp. 1111-1115
-
-
Wymenga, A.N.1
Eriksson, B.2
Salmela, P.I.3
Jacobsen, M.B.4
Van Cutsem, E.J.5
Fiasse, R.H.6
Valimaki, M.J.7
Renstrup, J.8
De Vries, E.G.9
Oberg, K.E.10
|